nodes	percent_of_prediction	percent_of_DWPC	metapath
Foscarnet—SLC22A6—Conjugated Estrogens—prostate cancer	0.00861	1	CbGbCtD
Foscarnet—SLC16A1—Pyruvate metabolism—LDHB—prostate cancer	0.00466	0.0531	CbGpPWpGaD
Foscarnet—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A3—prostate cancer	0.00447	0.0509	CbGpPWpGaD
Foscarnet—SLC16A1—Pyruvate metabolism—PDHA1—prostate cancer	0.00442	0.0503	CbGpPWpGaD
Foscarnet—SLC16A1—Basigin interactions—ITGA6—prostate cancer	0.00428	0.0487	CbGpPWpGaD
Foscarnet—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A1—prostate cancer	0.00364	0.0415	CbGpPWpGaD
Foscarnet—SLC16A1—Pyruvate metabolism and Citric Acid (TCA) cycle—LDHB—prostate cancer	0.00282	0.0321	CbGpPWpGaD
Foscarnet—SLC16A1—Pyruvate metabolism and Citric Acid (TCA) cycle—PDHA1—prostate cancer	0.00267	0.0304	CbGpPWpGaD
Foscarnet—SLC16A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A1—prostate cancer	0.00214	0.0244	CbGpPWpGaD
Foscarnet—SLC16A1—Pyruvate metabolism—RXRA—prostate cancer	0.00211	0.024	CbGpPWpGaD
Foscarnet—SLC16A1—Basigin interactions—CAV1—prostate cancer	0.00146	0.0167	CbGpPWpGaD
Foscarnet—SLC16A1—Cell surface interactions at the vascular wall—ITGA6—prostate cancer	0.00142	0.0162	CbGpPWpGaD
Foscarnet—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A1—prostate cancer	0.00139	0.0158	CbGpPWpGaD
Foscarnet—SLC16A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—prostate cancer	0.00138	0.0157	CbGpPWpGaD
Foscarnet—SLC16A1—Pyruvate metabolism and Citric Acid (TCA) cycle—RXRA—prostate cancer	0.00127	0.0145	CbGpPWpGaD
Foscarnet—SLC16A1—SLC-mediated transmembrane transport—SLC7A1—prostate cancer	0.00123	0.014	CbGpPWpGaD
Foscarnet—SLC16A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A1—prostate cancer	0.00112	0.0128	CbGpPWpGaD
Foscarnet—SLC16A1—Cell surface interactions at the vascular wall—GRB7—prostate cancer	0.00111	0.0126	CbGpPWpGaD
Foscarnet—SLC16A1—The citric acid (TCA) cycle and respiratory electron transport—LDHB—prostate cancer	0.00109	0.0125	CbGpPWpGaD
Foscarnet—SLC16A1—The citric acid (TCA) cycle and respiratory electron transport—PDHA1—prostate cancer	0.00104	0.0118	CbGpPWpGaD
Foscarnet—SLC16A1—The citric acid (TCA) cycle and respiratory electron transport—UCP3—prostate cancer	0.00104	0.0118	CbGpPWpGaD
Foscarnet—SLC16A1—SLC-mediated transmembrane transport—SLC39A1—prostate cancer	0.000972	0.0111	CbGpPWpGaD
Foscarnet—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—prostate cancer	0.000895	0.0102	CbGpPWpGaD
Foscarnet—SLC22A6—SLC-mediated transmembrane transport—SLC7A1—prostate cancer	0.000798	0.00909	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—HBG1—prostate cancer	0.000789	0.00899	CbGpPWpGaD
Foscarnet—SLC16A1—SLC-mediated transmembrane transport—SLC26A4—prostate cancer	0.000772	0.0088	CbGpPWpGaD
Foscarnet—SLC16A1—SLC-mediated transmembrane transport—SLC12A2—prostate cancer	0.000772	0.0088	CbGpPWpGaD
Foscarnet—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A1—prostate cancer	0.00073	0.00831	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—HBG2—prostate cancer	0.000671	0.00765	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—TMSB4X—prostate cancer	0.000671	0.00765	CbGpPWpGaD
Foscarnet—SLC22A6—SLC-mediated transmembrane transport—SLC39A1—prostate cancer	0.000631	0.00719	CbGpPWpGaD
Foscarnet—SLC16A1—SLC-mediated transmembrane transport—SLC22A3—prostate cancer	0.000627	0.00714	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—SLC7A1—prostate cancer	0.000625	0.00712	CbGpPWpGaD
Foscarnet—SLC16A1—Cell surface interactions at the vascular wall—ITGB3—prostate cancer	0.000566	0.00645	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—STX4—prostate cancer	0.000547	0.00623	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—RAD51B—prostate cancer	0.000547	0.00623	CbGpPWpGaD
Foscarnet—SLC16A1—SLC-mediated transmembrane transport—SLC22A1—prostate cancer	0.000511	0.00582	CbGpPWpGaD
Foscarnet—SLC22A6—SLC-mediated transmembrane transport—SLC12A2—prostate cancer	0.000501	0.00571	CbGpPWpGaD
Foscarnet—SLC22A6—SLC-mediated transmembrane transport—SLC26A4—prostate cancer	0.000501	0.00571	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—SLC39A1—prostate cancer	0.000494	0.00563	CbGpPWpGaD
Foscarnet—SLC16A1—The citric acid (TCA) cycle and respiratory electron transport—RXRA—prostate cancer	0.000494	0.00563	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—F9—prostate cancer	0.000493	0.00561	CbGpPWpGaD
Foscarnet—SLC16A1—Cell surface interactions at the vascular wall—CAV1—prostate cancer	0.000487	0.00555	CbGpPWpGaD
Foscarnet—SLC22A6—SLC-mediated transmembrane transport—SLC22A3—prostate cancer	0.000407	0.00463	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—SLC7A1—prostate cancer	0.000406	0.00462	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—CYP7B1—prostate cancer	0.000403	0.00459	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—SLC12A2—prostate cancer	0.000393	0.00447	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—SLC26A4—prostate cancer	0.000393	0.00447	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—ITGA6—prostate cancer	0.000386	0.00439	CbGpPWpGaD
Foscarnet—SLC16A1—SLC-mediated transmembrane transport—SLC5A5—prostate cancer	0.000373	0.00424	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—CD9—prostate cancer	0.000362	0.00413	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—HAO1—prostate cancer	0.000359	0.00409	CbGpPWpGaD
Foscarnet—SLC16A1—Cell surface interactions at the vascular wall—PIK3CB—prostate cancer	0.00034	0.00387	CbGpPWpGaD
Foscarnet—SLC22A6—SLC-mediated transmembrane transport—SLC22A1—prostate cancer	0.000332	0.00378	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—CLU—prostate cancer	0.000328	0.00373	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—SLC39A1—prostate cancer	0.000321	0.00365	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—SLC22A3—prostate cancer	0.000318	0.00363	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—GRB7—prostate cancer	0.0003	0.00342	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—ABCG5—prostate cancer	0.000294	0.00335	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PSAT1—prostate cancer	0.000293	0.00333	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—TST—prostate cancer	0.000293	0.00333	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—CSAD—prostate cancer	0.000293	0.00333	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—GRHL1—prostate cancer	0.000293	0.00333	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—CBR1—prostate cancer	0.000293	0.00333	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—ADI1—prostate cancer	0.000293	0.00333	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—GNG5—prostate cancer	0.000285	0.00325	CbGpPWpGaD
Foscarnet—SLC16A1—Cell surface interactions at the vascular wall—SRC—prostate cancer	0.000272	0.0031	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—UGT2B15—prostate cancer	0.000272	0.0031	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—GRHPR—prostate cancer	0.000272	0.0031	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—CKMT2—prostate cancer	0.000272	0.0031	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—UGT2B17—prostate cancer	0.000272	0.0031	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—CYP7B1—prostate cancer	0.000261	0.00298	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—SLC22A1—prostate cancer	0.00026	0.00296	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—NAGLU—prostate cancer	0.000256	0.00291	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PGAM2—prostate cancer	0.000256	0.00291	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—AOX1—prostate cancer	0.000256	0.00291	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—GSTM3—prostate cancer	0.000256	0.00291	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—SULT2B1—prostate cancer	0.000256	0.00291	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—MBTPS1—prostate cancer	0.000256	0.00291	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—RFK—prostate cancer	0.000256	0.00291	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—SLC26A4—prostate cancer	0.000255	0.0029	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—SLC12A2—prostate cancer	0.000255	0.0029	CbGpPWpGaD
Foscarnet—Myalgia—Capecitabine—prostate cancer	0.000252	0.000279	CcSEcCtD
Foscarnet—Chest pain—Capecitabine—prostate cancer	0.000252	0.000279	CcSEcCtD
Foscarnet—Arthralgia—Capecitabine—prostate cancer	0.000252	0.000279	CcSEcCtD
Foscarnet—Haematuria—Epirubicin—prostate cancer	0.000252	0.000278	CcSEcCtD
Foscarnet—Confusional state—Docetaxel—prostate cancer	0.000252	0.000278	CcSEcCtD
Foscarnet—Anxiety—Capecitabine—prostate cancer	0.000251	0.000278	CcSEcCtD
Foscarnet—Oedema—Docetaxel—prostate cancer	0.00025	0.000276	CcSEcCtD
Foscarnet—Discomfort—Capecitabine—prostate cancer	0.000249	0.000276	CcSEcCtD
Foscarnet—Infection—Docetaxel—prostate cancer	0.000248	0.000274	CcSEcCtD
Foscarnet—Weight decreased—Doxorubicin—prostate cancer	0.000248	0.000274	CcSEcCtD
Foscarnet—Sinusitis—Epirubicin—prostate cancer	0.000248	0.000274	CcSEcCtD
Foscarnet—Feeling abnormal—Etoposide—prostate cancer	0.000247	0.000274	CcSEcCtD
Foscarnet—Diarrhoea—Mitoxantrone—prostate cancer	0.000247	0.000273	CcSEcCtD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—GNG5—prostate cancer	0.000247	0.00281	CbGpPWpGaD
Foscarnet—Dry mouth—Capecitabine—prostate cancer	0.000246	0.000273	CcSEcCtD
Foscarnet—Vomiting—Estradiol—prostate cancer	0.000246	0.000273	CcSEcCtD
Foscarnet—Agranulocytosis—Epirubicin—prostate cancer	0.000246	0.000273	CcSEcCtD
Foscarnet—Gastrointestinal pain—Etoposide—prostate cancer	0.000246	0.000272	CcSEcCtD
Foscarnet—Ill-defined disorder—Prednisone—prostate cancer	0.000245	0.000271	CcSEcCtD
Foscarnet—Thrombocytopenia—Docetaxel—prostate cancer	0.000244	0.00027	CcSEcCtD
Foscarnet—Rash—Estradiol—prostate cancer	0.000244	0.00027	CcSEcCtD
Foscarnet—Dermatitis—Estradiol—prostate cancer	0.000244	0.00027	CcSEcCtD
Foscarnet—Anaemia—Prednisone—prostate cancer	0.000244	0.00027	CcSEcCtD
Foscarnet—Confusional state—Capecitabine—prostate cancer	0.000244	0.00027	CcSEcCtD
Foscarnet—SLC16A1—Hemostasis—PRKACB—prostate cancer	0.000243	0.00277	CbGpPWpGaD
Foscarnet—Headache—Estradiol—prostate cancer	0.000243	0.000269	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—CYP3A43—prostate cancer	0.000243	0.00276	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—AMACR—prostate cancer	0.000243	0.00276	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—NAT1—prostate cancer	0.000243	0.00276	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—DEGS1—prostate cancer	0.000243	0.00276	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—SRD5A2—prostate cancer	0.000243	0.00276	CbGpPWpGaD
Foscarnet—Agitation—Prednisone—prostate cancer	0.000242	0.000268	CcSEcCtD
Foscarnet—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	0.000242	0.000268	CcSEcCtD
Foscarnet—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—prostate cancer	0.000242	0.00275	CbGpPWpGaD
Foscarnet—Oedema—Capecitabine—prostate cancer	0.000242	0.000267	CcSEcCtD
Foscarnet—Renal failure—Doxorubicin—prostate cancer	0.00024	0.000266	CcSEcCtD
Foscarnet—Infection—Capecitabine—prostate cancer	0.00024	0.000266	CcSEcCtD
Foscarnet—Neuropathy peripheral—Doxorubicin—prostate cancer	0.000239	0.000265	CcSEcCtD
Foscarnet—Anorexia—Docetaxel—prostate cancer	0.000238	0.000263	CcSEcCtD
Foscarnet—Malaise—Prednisone—prostate cancer	0.000238	0.000263	CcSEcCtD
Foscarnet—Rhinitis—Epirubicin—prostate cancer	0.000237	0.000263	CcSEcCtD
Foscarnet—Body temperature increased—Etoposide—prostate cancer	0.000237	0.000263	CcSEcCtD
Foscarnet—Abdominal pain—Etoposide—prostate cancer	0.000237	0.000263	CcSEcCtD
Foscarnet—Urinary tract infection—Doxorubicin—prostate cancer	0.000237	0.000263	CcSEcCtD
Foscarnet—Conjunctivitis—Doxorubicin—prostate cancer	0.000237	0.000263	CcSEcCtD
Foscarnet—SLC16A1—Hemostasis—THBS1—prostate cancer	0.000237	0.0027	CbGpPWpGaD
Foscarnet—Thrombocytopenia—Capecitabine—prostate cancer	0.000237	0.000262	CcSEcCtD
Foscarnet—Hypoaesthesia—Epirubicin—prostate cancer	0.000236	0.000261	CcSEcCtD
Foscarnet—Pharyngitis—Epirubicin—prostate cancer	0.000235	0.00026	CcSEcCtD
Foscarnet—Hyperhidrosis—Capecitabine—prostate cancer	0.000234	0.000258	CcSEcCtD
Foscarnet—Hypotension—Docetaxel—prostate cancer	0.000233	0.000258	CcSEcCtD
Foscarnet—Haematuria—Doxorubicin—prostate cancer	0.000233	0.000258	CcSEcCtD
Foscarnet—Urethral disorder—Epirubicin—prostate cancer	0.000232	0.000257	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—HSD17B1—prostate cancer	0.000231	0.00264	CbGpPWpGaD
Foscarnet—Anorexia—Capecitabine—prostate cancer	0.00023	0.000255	CcSEcCtD
Foscarnet—Nausea—Estradiol—prostate cancer	0.00023	0.000255	CcSEcCtD
Foscarnet—Vomiting—Mitoxantrone—prostate cancer	0.00023	0.000254	CcSEcCtD
Foscarnet—SLC16A1—Hemostasis—PRKCZ—prostate cancer	0.000229	0.00261	CbGpPWpGaD
Foscarnet—Sinusitis—Doxorubicin—prostate cancer	0.000229	0.000254	CcSEcCtD
Foscarnet—Convulsion—Prednisone—prostate cancer	0.000228	0.000253	CcSEcCtD
Foscarnet—Agranulocytosis—Doxorubicin—prostate cancer	0.000228	0.000252	CcSEcCtD
Foscarnet—Hypertension—Prednisone—prostate cancer	0.000228	0.000252	CcSEcCtD
Foscarnet—Rash—Mitoxantrone—prostate cancer	0.000228	0.000252	CcSEcCtD
Foscarnet—Dermatitis—Mitoxantrone—prostate cancer	0.000227	0.000252	CcSEcCtD
Foscarnet—Musculoskeletal discomfort—Docetaxel—prostate cancer	0.000227	0.000252	CcSEcCtD
Foscarnet—Headache—Mitoxantrone—prostate cancer	0.000226	0.00025	CcSEcCtD
Foscarnet—Hypotension—Capecitabine—prostate cancer	0.000226	0.00025	CcSEcCtD
Foscarnet—Insomnia—Docetaxel—prostate cancer	0.000226	0.00025	CcSEcCtD
Foscarnet—SLC16A1—Cell surface interactions at the vascular wall—KRAS—prostate cancer	0.000225	0.00257	CbGpPWpGaD
Foscarnet—Arthralgia—Prednisone—prostate cancer	0.000224	0.000248	CcSEcCtD
Foscarnet—Myalgia—Prednisone—prostate cancer	0.000224	0.000248	CcSEcCtD
Foscarnet—Paraesthesia—Docetaxel—prostate cancer	0.000224	0.000248	CcSEcCtD
Foscarnet—Erythema multiforme—Epirubicin—prostate cancer	0.000224	0.000248	CcSEcCtD
Foscarnet—Anxiety—Prednisone—prostate cancer	0.000224	0.000248	CcSEcCtD
Foscarnet—Dyspnoea—Docetaxel—prostate cancer	0.000222	0.000246	CcSEcCtD
Foscarnet—Somnolence—Docetaxel—prostate cancer	0.000222	0.000245	CcSEcCtD
Foscarnet—Discomfort—Prednisone—prostate cancer	0.000222	0.000245	CcSEcCtD
Foscarnet—Eye disorder—Epirubicin—prostate cancer	0.000221	0.000245	CcSEcCtD
Foscarnet—Musculoskeletal discomfort—Capecitabine—prostate cancer	0.00022	0.000244	CcSEcCtD
Foscarnet—Flushing—Epirubicin—prostate cancer	0.00022	0.000243	CcSEcCtD
Foscarnet—Rhinitis—Doxorubicin—prostate cancer	0.00022	0.000243	CcSEcCtD
Foscarnet—Dyspepsia—Docetaxel—prostate cancer	0.00022	0.000243	CcSEcCtD
Foscarnet—Insomnia—Capecitabine—prostate cancer	0.000219	0.000242	CcSEcCtD
Foscarnet—Hypoaesthesia—Doxorubicin—prostate cancer	0.000218	0.000241	CcSEcCtD
Foscarnet—Pharyngitis—Doxorubicin—prostate cancer	0.000218	0.000241	CcSEcCtD
Foscarnet—Paraesthesia—Capecitabine—prostate cancer	0.000217	0.00024	CcSEcCtD
Foscarnet—Decreased appetite—Docetaxel—prostate cancer	0.000217	0.00024	CcSEcCtD
Foscarnet—Asthenia—Etoposide—prostate cancer	0.000215	0.000238	CcSEcCtD
Foscarnet—Dyspnoea—Capecitabine—prostate cancer	0.000215	0.000238	CcSEcCtD
Foscarnet—Oedema—Prednisone—prostate cancer	0.000215	0.000238	CcSEcCtD
Foscarnet—Fatigue—Docetaxel—prostate cancer	0.000215	0.000238	CcSEcCtD
Foscarnet—Urethral disorder—Doxorubicin—prostate cancer	0.000215	0.000238	CcSEcCtD
Foscarnet—Nausea—Mitoxantrone—prostate cancer	0.000214	0.000237	CcSEcCtD
Foscarnet—Infection—Prednisone—prostate cancer	0.000214	0.000237	CcSEcCtD
Foscarnet—Pain—Docetaxel—prostate cancer	0.000213	0.000236	CcSEcCtD
Foscarnet—Constipation—Docetaxel—prostate cancer	0.000213	0.000236	CcSEcCtD
Foscarnet—Dyspepsia—Capecitabine—prostate cancer	0.000213	0.000235	CcSEcCtD
Foscarnet—Chills—Epirubicin—prostate cancer	0.000213	0.000235	CcSEcCtD
Foscarnet—Pruritus—Etoposide—prostate cancer	0.000212	0.000235	CcSEcCtD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—PRKACB—prostate cancer	0.00021	0.0024	CbGpPWpGaD
Foscarnet—Decreased appetite—Capecitabine—prostate cancer	0.00021	0.000232	CcSEcCtD
Foscarnet—Fatigue—Capecitabine—prostate cancer	0.000208	0.000231	CcSEcCtD
Foscarnet—Hyperhidrosis—Prednisone—prostate cancer	0.000208	0.00023	CcSEcCtD
Foscarnet—Erythema multiforme—Doxorubicin—prostate cancer	0.000207	0.000229	CcSEcCtD
Foscarnet—SLC16A1—Cell surface interactions at the vascular wall—PIK3CA—prostate cancer	0.000207	0.00236	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—SLC22A3—prostate cancer	0.000207	0.00235	CbGpPWpGaD
Foscarnet—Pain—Capecitabine—prostate cancer	0.000207	0.000229	CcSEcCtD
Foscarnet—Constipation—Capecitabine—prostate cancer	0.000207	0.000229	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—B4GALT4—prostate cancer	0.000206	0.00235	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—HPGD—prostate cancer	0.000206	0.00235	CbGpPWpGaD
Foscarnet—Feeling abnormal—Docetaxel—prostate cancer	0.000206	0.000228	CcSEcCtD
Foscarnet—Diarrhoea—Etoposide—prostate cancer	0.000205	0.000227	CcSEcCtD
Foscarnet—Anorexia—Prednisone—prostate cancer	0.000205	0.000227	CcSEcCtD
Foscarnet—Eye disorder—Doxorubicin—prostate cancer	0.000205	0.000227	CcSEcCtD
Foscarnet—Gastrointestinal pain—Docetaxel—prostate cancer	0.000204	0.000226	CcSEcCtD
Foscarnet—Flushing—Doxorubicin—prostate cancer	0.000203	0.000225	CcSEcCtD
Foscarnet—Flatulence—Epirubicin—prostate cancer	0.000203	0.000225	CcSEcCtD
Foscarnet—Tension—Epirubicin—prostate cancer	0.000202	0.000224	CcSEcCtD
Foscarnet—Nervousness—Epirubicin—prostate cancer	0.0002	0.000222	CcSEcCtD
Foscarnet—Back pain—Epirubicin—prostate cancer	0.000199	0.000221	CcSEcCtD
Foscarnet—Feeling abnormal—Capecitabine—prostate cancer	0.000199	0.00022	CcSEcCtD
Foscarnet—Dizziness—Etoposide—prostate cancer	0.000199	0.00022	CcSEcCtD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—NCOA2—prostate cancer	0.000198	0.00226	CbGpPWpGaD
Foscarnet—Muscle spasms—Epirubicin—prostate cancer	0.000198	0.000219	CcSEcCtD
Foscarnet—Gastrointestinal pain—Capecitabine—prostate cancer	0.000198	0.000219	CcSEcCtD
Foscarnet—Body temperature increased—Docetaxel—prostate cancer	0.000197	0.000218	CcSEcCtD
Foscarnet—Abdominal pain—Docetaxel—prostate cancer	0.000197	0.000218	CcSEcCtD
Foscarnet—Chills—Doxorubicin—prostate cancer	0.000197	0.000218	CcSEcCtD
Foscarnet—Musculoskeletal discomfort—Prednisone—prostate cancer	0.000196	0.000217	CcSEcCtD
Foscarnet—SLC16A1—Hemostasis—PRKCQ—prostate cancer	0.000195	0.00222	CbGpPWpGaD
Foscarnet—Insomnia—Prednisone—prostate cancer	0.000195	0.000215	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—TNFRSF21—prostate cancer	0.000194	0.00221	CbGpPWpGaD
Foscarnet—Paraesthesia—Prednisone—prostate cancer	0.000193	0.000214	CcSEcCtD
Foscarnet—SLC16A1—Hemostasis—PLAUR—prostate cancer	0.000193	0.00219	CbGpPWpGaD
Foscarnet—Ill-defined disorder—Epirubicin—prostate cancer	0.000191	0.000212	CcSEcCtD
Foscarnet—Abdominal pain—Capecitabine—prostate cancer	0.000191	0.000211	CcSEcCtD
Foscarnet—Body temperature increased—Capecitabine—prostate cancer	0.000191	0.000211	CcSEcCtD
Foscarnet—Vomiting—Etoposide—prostate cancer	0.000191	0.000211	CcSEcCtD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—ABCG5—prostate cancer	0.000191	0.00217	CbGpPWpGaD
Foscarnet—Anaemia—Epirubicin—prostate cancer	0.000191	0.000211	CcSEcCtD
Foscarnet—Agitation—Epirubicin—prostate cancer	0.00019	0.00021	CcSEcCtD
Foscarnet—Dyspepsia—Prednisone—prostate cancer	0.000189	0.00021	CcSEcCtD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—SLC5A5—prostate cancer	0.000189	0.00216	CbGpPWpGaD
Foscarnet—Rash—Etoposide—prostate cancer	0.000189	0.00021	CcSEcCtD
Foscarnet—Dermatitis—Etoposide—prostate cancer	0.000189	0.000209	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—CYP7B1—prostate cancer	0.000189	0.00215	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—MTAP—prostate cancer	0.000189	0.00215	CbGpPWpGaD
Foscarnet—Headache—Etoposide—prostate cancer	0.000188	0.000208	CcSEcCtD
Foscarnet—Flatulence—Doxorubicin—prostate cancer	0.000188	0.000208	CcSEcCtD
Foscarnet—Tension—Doxorubicin—prostate cancer	0.000187	0.000207	CcSEcCtD
Foscarnet—Decreased appetite—Prednisone—prostate cancer	0.000187	0.000207	CcSEcCtD
Foscarnet—Malaise—Epirubicin—prostate cancer	0.000186	0.000206	CcSEcCtD
Foscarnet—Fatigue—Prednisone—prostate cancer	0.000186	0.000205	CcSEcCtD
Foscarnet—Nervousness—Doxorubicin—prostate cancer	0.000185	0.000205	CcSEcCtD
Foscarnet—Leukopenia—Epirubicin—prostate cancer	0.000185	0.000204	CcSEcCtD
Foscarnet—Back pain—Doxorubicin—prostate cancer	0.000185	0.000204	CcSEcCtD
Foscarnet—Constipation—Prednisone—prostate cancer	0.000184	0.000204	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—SRD5A1—prostate cancer	0.000184	0.00209	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—SULT1E1—prostate cancer	0.000184	0.00209	CbGpPWpGaD
Foscarnet—Muscle spasms—Doxorubicin—prostate cancer	0.000183	0.000203	CcSEcCtD
Foscarnet—Palpitations—Epirubicin—prostate cancer	0.000182	0.000202	CcSEcCtD
Foscarnet—Cough—Epirubicin—prostate cancer	0.00018	0.000199	CcSEcCtD
Foscarnet—Asthenia—Docetaxel—prostate cancer	0.000179	0.000198	CcSEcCtD
Foscarnet—SLC16A1—Hemostasis—VAV3—prostate cancer	0.000179	0.00204	CbGpPWpGaD
Foscarnet—Convulsion—Epirubicin—prostate cancer	0.000179	0.000198	CcSEcCtD
Foscarnet—Nausea—Etoposide—prostate cancer	0.000178	0.000197	CcSEcCtD
Foscarnet—Hypertension—Epirubicin—prostate cancer	0.000178	0.000197	CcSEcCtD
Foscarnet—Feeling abnormal—Prednisone—prostate cancer	0.000177	0.000196	CcSEcCtD
Foscarnet—Ill-defined disorder—Doxorubicin—prostate cancer	0.000177	0.000196	CcSEcCtD
Foscarnet—Pruritus—Docetaxel—prostate cancer	0.000177	0.000195	CcSEcCtD
Foscarnet—Anaemia—Doxorubicin—prostate cancer	0.000176	0.000195	CcSEcCtD
Foscarnet—Gastrointestinal pain—Prednisone—prostate cancer	0.000176	0.000195	CcSEcCtD
Foscarnet—Myalgia—Epirubicin—prostate cancer	0.000176	0.000194	CcSEcCtD
Foscarnet—Chest pain—Epirubicin—prostate cancer	0.000176	0.000194	CcSEcCtD
Foscarnet—Arthralgia—Epirubicin—prostate cancer	0.000176	0.000194	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—ACSL4—prostate cancer	0.000175	0.002	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—HSD17B3—prostate cancer	0.000175	0.002	CbGpPWpGaD
Foscarnet—Agitation—Doxorubicin—prostate cancer	0.000175	0.000194	CcSEcCtD
Foscarnet—Anxiety—Epirubicin—prostate cancer	0.000175	0.000194	CcSEcCtD
Foscarnet—Discomfort—Epirubicin—prostate cancer	0.000173	0.000192	CcSEcCtD
Foscarnet—SLC16A1—Hemostasis—ITPR1—prostate cancer	0.000173	0.00197	CbGpPWpGaD
Foscarnet—Asthenia—Capecitabine—prostate cancer	0.000173	0.000192	CcSEcCtD
Foscarnet—Malaise—Doxorubicin—prostate cancer	0.000172	0.00019	CcSEcCtD
Foscarnet—Dry mouth—Epirubicin—prostate cancer	0.000172	0.00019	CcSEcCtD
Foscarnet—Pruritus—Capecitabine—prostate cancer	0.000171	0.000189	CcSEcCtD
Foscarnet—Leukopenia—Doxorubicin—prostate cancer	0.000171	0.000189	CcSEcCtD
Foscarnet—Diarrhoea—Docetaxel—prostate cancer	0.000171	0.000189	CcSEcCtD
Foscarnet—Body temperature increased—Prednisone—prostate cancer	0.00017	0.000188	CcSEcCtD
Foscarnet—Abdominal pain—Prednisone—prostate cancer	0.00017	0.000188	CcSEcCtD
Foscarnet—Confusional state—Epirubicin—prostate cancer	0.00017	0.000188	CcSEcCtD
Foscarnet—Palpitations—Doxorubicin—prostate cancer	0.000169	0.000187	CcSEcCtD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—SLC22A1—prostate cancer	0.000168	0.00192	CbGpPWpGaD
Foscarnet—Oedema—Epirubicin—prostate cancer	0.000168	0.000186	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—UMPS—prostate cancer	0.000168	0.00192	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PHGDH—prostate cancer	0.000168	0.00192	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—ARG2—prostate cancer	0.000168	0.00192	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—NCOA1—prostate cancer	0.000167	0.00191	CbGpPWpGaD
Foscarnet—Infection—Epirubicin—prostate cancer	0.000167	0.000185	CcSEcCtD
Foscarnet—Cough—Doxorubicin—prostate cancer	0.000167	0.000184	CcSEcCtD
Foscarnet—Convulsion—Doxorubicin—prostate cancer	0.000165	0.000183	CcSEcCtD
Foscarnet—Diarrhoea—Capecitabine—prostate cancer	0.000165	0.000183	CcSEcCtD
Foscarnet—Dizziness—Docetaxel—prostate cancer	0.000165	0.000183	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—LDHB—prostate cancer	0.000165	0.00188	CbGpPWpGaD
Foscarnet—Thrombocytopenia—Epirubicin—prostate cancer	0.000165	0.000182	CcSEcCtD
Foscarnet—Hypertension—Doxorubicin—prostate cancer	0.000165	0.000182	CcSEcCtD
Foscarnet—Hyperhidrosis—Epirubicin—prostate cancer	0.000163	0.00018	CcSEcCtD
Foscarnet—Myalgia—Doxorubicin—prostate cancer	0.000162	0.00018	CcSEcCtD
Foscarnet—Chest pain—Doxorubicin—prostate cancer	0.000162	0.00018	CcSEcCtD
Foscarnet—Arthralgia—Doxorubicin—prostate cancer	0.000162	0.00018	CcSEcCtD
Foscarnet—Anxiety—Doxorubicin—prostate cancer	0.000162	0.000179	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—CYP3A5—prostate cancer	0.000162	0.00184	CbGpPWpGaD
Foscarnet—Discomfort—Doxorubicin—prostate cancer	0.00016	0.000178	CcSEcCtD
Foscarnet—Anorexia—Epirubicin—prostate cancer	0.00016	0.000178	CcSEcCtD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—GNG5—prostate cancer	0.00016	0.00183	CbGpPWpGaD
Foscarnet—Dizziness—Capecitabine—prostate cancer	0.00016	0.000177	CcSEcCtD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—RXRA—prostate cancer	0.000159	0.00181	CbGpPWpGaD
Foscarnet—Dry mouth—Doxorubicin—prostate cancer	0.000159	0.000176	CcSEcCtD
Foscarnet—Vomiting—Docetaxel—prostate cancer	0.000159	0.000176	CcSEcCtD
Foscarnet—Rash—Docetaxel—prostate cancer	0.000157	0.000174	CcSEcCtD
Foscarnet—Hypotension—Epirubicin—prostate cancer	0.000157	0.000174	CcSEcCtD
Foscarnet—Dermatitis—Docetaxel—prostate cancer	0.000157	0.000174	CcSEcCtD
Foscarnet—Confusional state—Doxorubicin—prostate cancer	0.000157	0.000174	CcSEcCtD
Foscarnet—Headache—Docetaxel—prostate cancer	0.000156	0.000173	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—PDHA1—prostate cancer	0.000156	0.00178	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—GSTA3—prostate cancer	0.000156	0.00178	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—TCN2—prostate cancer	0.000156	0.00178	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—UCP3—prostate cancer	0.000156	0.00178	CbGpPWpGaD
Foscarnet—Oedema—Doxorubicin—prostate cancer	0.000156	0.000172	CcSEcCtD
Foscarnet—Infection—Doxorubicin—prostate cancer	0.000155	0.000171	CcSEcCtD
Foscarnet—Asthenia—Prednisone—prostate cancer	0.000154	0.000171	CcSEcCtD
Foscarnet—Vomiting—Capecitabine—prostate cancer	0.000154	0.00017	CcSEcCtD
Foscarnet—SLC16A1—Hemostasis—ITGB3—prostate cancer	0.000153	0.00175	CbGpPWpGaD
Foscarnet—Musculoskeletal discomfort—Epirubicin—prostate cancer	0.000153	0.00017	CcSEcCtD
Foscarnet—Thrombocytopenia—Doxorubicin—prostate cancer	0.000152	0.000169	CcSEcCtD
Foscarnet—Rash—Capecitabine—prostate cancer	0.000152	0.000169	CcSEcCtD
Foscarnet—Pruritus—Prednisone—prostate cancer	0.000152	0.000168	CcSEcCtD
Foscarnet—Insomnia—Epirubicin—prostate cancer	0.000152	0.000168	CcSEcCtD
Foscarnet—Dermatitis—Capecitabine—prostate cancer	0.000152	0.000168	CcSEcCtD
Foscarnet—Headache—Capecitabine—prostate cancer	0.000151	0.000167	CcSEcCtD
Foscarnet—Paraesthesia—Epirubicin—prostate cancer	0.000151	0.000167	CcSEcCtD
Foscarnet—Hyperhidrosis—Doxorubicin—prostate cancer	0.000151	0.000167	CcSEcCtD
Foscarnet—Dyspnoea—Epirubicin—prostate cancer	0.00015	0.000166	CcSEcCtD
Foscarnet—Somnolence—Epirubicin—prostate cancer	0.00015	0.000166	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—SLC22A3—prostate cancer	0.000149	0.0017	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—HSD3B1—prostate cancer	0.000149	0.0017	CbGpPWpGaD
Foscarnet—Anorexia—Doxorubicin—prostate cancer	0.000148	0.000164	CcSEcCtD
Foscarnet—Nausea—Docetaxel—prostate cancer	0.000148	0.000164	CcSEcCtD
Foscarnet—Dyspepsia—Epirubicin—prostate cancer	0.000148	0.000164	CcSEcCtD
Foscarnet—Diarrhoea—Prednisone—prostate cancer	0.000147	0.000163	CcSEcCtD
Foscarnet—Decreased appetite—Epirubicin—prostate cancer	0.000146	0.000162	CcSEcCtD
Foscarnet—Hypotension—Doxorubicin—prostate cancer	0.000146	0.000161	CcSEcCtD
Foscarnet—Fatigue—Epirubicin—prostate cancer	0.000145	0.000161	CcSEcCtD
Foscarnet—Pain—Epirubicin—prostate cancer	0.000144	0.000159	CcSEcCtD
Foscarnet—Constipation—Epirubicin—prostate cancer	0.000144	0.000159	CcSEcCtD
Foscarnet—Nausea—Capecitabine—prostate cancer	0.000143	0.000159	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—TBXAS1—prostate cancer	0.000143	0.00163	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—GSTA4—prostate cancer	0.000143	0.00163	CbGpPWpGaD
Foscarnet—Dizziness—Prednisone—prostate cancer	0.000142	0.000157	CcSEcCtD
Foscarnet—Musculoskeletal discomfort—Doxorubicin—prostate cancer	0.000142	0.000157	CcSEcCtD
Foscarnet—Insomnia—Doxorubicin—prostate cancer	0.000141	0.000156	CcSEcCtD
Foscarnet—Paraesthesia—Doxorubicin—prostate cancer	0.00014	0.000155	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—GSTA2—prostate cancer	0.000139	0.00159	CbGpPWpGaD
Foscarnet—Dyspnoea—Doxorubicin—prostate cancer	0.000139	0.000154	CcSEcCtD
Foscarnet—Feeling abnormal—Epirubicin—prostate cancer	0.000139	0.000153	CcSEcCtD
Foscarnet—Somnolence—Doxorubicin—prostate cancer	0.000138	0.000153	CcSEcCtD
Foscarnet—Gastrointestinal pain—Epirubicin—prostate cancer	0.000138	0.000152	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—SULT1A1—prostate cancer	0.000138	0.00157	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—ABCG5—prostate cancer	0.000138	0.00157	CbGpPWpGaD
Foscarnet—Dyspepsia—Doxorubicin—prostate cancer	0.000137	0.000152	CcSEcCtD
Foscarnet—Vomiting—Prednisone—prostate cancer	0.000137	0.000151	CcSEcCtD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—PRKACB—prostate cancer	0.000137	0.00156	CbGpPWpGaD
Foscarnet—Rash—Prednisone—prostate cancer	0.000136	0.00015	CcSEcCtD
Foscarnet—Dermatitis—Prednisone—prostate cancer	0.000136	0.00015	CcSEcCtD
Foscarnet—Decreased appetite—Doxorubicin—prostate cancer	0.000135	0.00015	CcSEcCtD
Foscarnet—SLC16A1—Hemostasis—PLAU—prostate cancer	0.000135	0.00154	CbGpPWpGaD
Foscarnet—Headache—Prednisone—prostate cancer	0.000135	0.000149	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—GSTA1—prostate cancer	0.000134	0.00153	CbGpPWpGaD
Foscarnet—Fatigue—Doxorubicin—prostate cancer	0.000134	0.000149	CcSEcCtD
Foscarnet—Pain—Doxorubicin—prostate cancer	0.000133	0.000147	CcSEcCtD
Foscarnet—Constipation—Doxorubicin—prostate cancer	0.000133	0.000147	CcSEcCtD
Foscarnet—Body temperature increased—Epirubicin—prostate cancer	0.000133	0.000147	CcSEcCtD
Foscarnet—Abdominal pain—Epirubicin—prostate cancer	0.000133	0.000147	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—GSTO1—prostate cancer	0.000133	0.00151	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—HSD3B2—prostate cancer	0.000133	0.00151	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—NAT2—prostate cancer	0.000133	0.00151	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—CAV1—prostate cancer	0.000132	0.0015	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—NCOA2—prostate cancer	0.000129	0.00147	CbGpPWpGaD
Foscarnet—Feeling abnormal—Doxorubicin—prostate cancer	0.000128	0.000142	CcSEcCtD
Foscarnet—Nausea—Prednisone—prostate cancer	0.000128	0.000141	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—CYP2C18—prostate cancer	0.000127	0.00145	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PLCB2—prostate cancer	0.000127	0.00145	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—LRP2—prostate cancer	0.000127	0.00145	CbGpPWpGaD
Foscarnet—Gastrointestinal pain—Doxorubicin—prostate cancer	0.000127	0.000141	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—P4HB—prostate cancer	0.000125	0.00142	CbGpPWpGaD
Foscarnet—Abdominal pain—Doxorubicin—prostate cancer	0.000123	0.000136	CcSEcCtD
Foscarnet—Body temperature increased—Doxorubicin—prostate cancer	0.000123	0.000136	CcSEcCtD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—SLC5A5—prostate cancer	0.000123	0.0014	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—SLC22A1—prostate cancer	0.000122	0.00138	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—PPARA—prostate cancer	0.000122	0.00138	CbGpPWpGaD
Foscarnet—Asthenia—Epirubicin—prostate cancer	0.000121	0.000134	CcSEcCtD
Foscarnet—SLC16A1—Hemostasis—PIK3CG—prostate cancer	0.00012	0.00137	CbGpPWpGaD
Foscarnet—Pruritus—Epirubicin—prostate cancer	0.000119	0.000132	CcSEcCtD
Foscarnet—SLC16A1—Hemostasis—EGF—prostate cancer	0.000119	0.00135	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—SULT2A1—prostate cancer	0.000118	0.00135	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—MED12—prostate cancer	0.000117	0.00133	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—GNG5—prostate cancer	0.000116	0.00132	CbGpPWpGaD
Foscarnet—Diarrhoea—Epirubicin—prostate cancer	0.000115	0.000127	CcSEcCtD
Foscarnet—Asthenia—Doxorubicin—prostate cancer	0.000112	0.000124	CcSEcCtD
Foscarnet—SLC16A1—Hemostasis—CREBBP—prostate cancer	0.000111	0.00127	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—NCOA3—prostate cancer	0.000111	0.00127	CbGpPWpGaD
Foscarnet—Dizziness—Epirubicin—prostate cancer	0.000111	0.000123	CcSEcCtD
Foscarnet—Pruritus—Doxorubicin—prostate cancer	0.00011	0.000122	CcSEcCtD
Foscarnet—SLC16A1—Hemostasis—IGF1—prostate cancer	0.00011	0.00125	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—NCOA1—prostate cancer	0.000109	0.00124	CbGpPWpGaD
Foscarnet—Vomiting—Epirubicin—prostate cancer	0.000107	0.000118	CcSEcCtD
Foscarnet—Diarrhoea—Doxorubicin—prostate cancer	0.000107	0.000118	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—HPGDS—prostate cancer	0.000106	0.00121	CbGpPWpGaD
Foscarnet—Rash—Epirubicin—prostate cancer	0.000106	0.000117	CcSEcCtD
Foscarnet—Dermatitis—Epirubicin—prostate cancer	0.000106	0.000117	CcSEcCtD
Foscarnet—SLC16A1—Hemostasis—PIK3CD—prostate cancer	0.000106	0.0012	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—CYP2C19—prostate cancer	0.000106	0.0012	CbGpPWpGaD
Foscarnet—Headache—Epirubicin—prostate cancer	0.000105	0.000117	CcSEcCtD
Foscarnet—SLC16A1—Hemostasis—SERPINE1—prostate cancer	0.000105	0.00119	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—RXRA—prostate cancer	0.000103	0.00118	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—GSTT1—prostate cancer	0.000103	0.00117	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—ACHE—prostate cancer	0.000103	0.00117	CbGpPWpGaD
Foscarnet—Dizziness—Doxorubicin—prostate cancer	0.000103	0.000114	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—CYP2A6—prostate cancer	0.000102	0.00116	CbGpPWpGaD
Foscarnet—Nausea—Epirubicin—prostate cancer	0.0001	0.000111	CcSEcCtD
Foscarnet—SLC16A1—Hemostasis—NOS3—prostate cancer	9.98e-05	0.00114	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—AKR1C3—prostate cancer	9.91e-05	0.00113	CbGpPWpGaD
Foscarnet—Vomiting—Doxorubicin—prostate cancer	9.9e-05	0.00011	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—PRKACB—prostate cancer	9.86e-05	0.00112	CbGpPWpGaD
Foscarnet—Rash—Doxorubicin—prostate cancer	9.82e-05	0.000109	CcSEcCtD
Foscarnet—Dermatitis—Doxorubicin—prostate cancer	9.81e-05	0.000109	CcSEcCtD
Foscarnet—Headache—Doxorubicin—prostate cancer	9.76e-05	0.000108	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—CYP17A1—prostate cancer	9.76e-05	0.00111	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—JAK2—prostate cancer	9.7e-05	0.0011	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—CREBBP—prostate cancer	9.65e-05	0.0011	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—NCOA2—prostate cancer	9.3e-05	0.00106	CbGpPWpGaD
Foscarnet—Nausea—Doxorubicin—prostate cancer	9.25e-05	0.000102	CcSEcCtD
Foscarnet—SLC16A1—Hemostasis—PIK3CB—prostate cancer	9.21e-05	0.00105	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—SLC5A5—prostate cancer	8.87e-05	0.00101	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—CYP2E1—prostate cancer	8.66e-05	0.000987	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—NQO1—prostate cancer	8.56e-05	0.000976	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—IL2—prostate cancer	8.46e-05	0.000964	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—TH—prostate cancer	8.44e-05	0.000962	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—CYP3A4—prostate cancer	8.35e-05	0.000951	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—CYP1B1—prostate cancer	8.21e-05	0.000935	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—GGT1—prostate cancer	7.95e-05	0.000906	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—PPARA—prostate cancer	7.89e-05	0.000898	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—NCOA1—prostate cancer	7.83e-05	0.000892	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—CYP19A1—prostate cancer	7.72e-05	0.000879	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—EP300—prostate cancer	7.59e-05	0.000865	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—RXRA—prostate cancer	7.45e-05	0.000849	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—SRC—prostate cancer	7.38e-05	0.000841	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—VEGFA—prostate cancer	7.19e-05	0.000819	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—COMT—prostate cancer	7.18e-05	0.000818	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—GSTP1—prostate cancer	7.14e-05	0.000814	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—ITPR1—prostate cancer	7.03e-05	0.000801	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—TYMS—prostate cancer	6.64e-05	0.000756	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—TGFB1—prostate cancer	6.6e-05	0.000752	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—GSTM1—prostate cancer	6.56e-05	0.000748	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—LPL—prostate cancer	6.44e-05	0.000734	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—CREBBP—prostate cancer	6.26e-05	0.000713	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—CYP1A1—prostate cancer	6.22e-05	0.000709	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—ERCC2—prostate cancer	6.17e-05	0.000703	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—KRAS—prostate cancer	6.11e-05	0.000696	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—MTHFR—prostate cancer	5.8e-05	0.000661	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PPARA—prostate cancer	5.69e-05	0.000648	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—PIK3CA—prostate cancer	5.62e-05	0.00064	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—TP53—prostate cancer	5.43e-05	0.000619	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—CAV1—prostate cancer	5.35e-05	0.00061	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PIK3CG—prostate cancer	4.87e-05	0.000555	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—INS—prostate cancer	4.61e-05	0.000526	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—AKT1—prostate cancer	4.59e-05	0.000523	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—CREBBP—prostate cancer	4.52e-05	0.000515	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PIK3CD—prostate cancer	4.29e-05	0.000488	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—NOS3—prostate cancer	4.05e-05	0.000461	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PIK3CB—prostate cancer	3.73e-05	0.000425	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PTGS2—prostate cancer	3.7e-05	0.000422	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PTEN—prostate cancer	3.23e-05	0.000368	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—EP300—prostate cancer	3.08e-05	0.000351	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PIK3CA—prostate cancer	2.28e-05	0.000259	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—AKT1—prostate cancer	1.86e-05	0.000212	CbGpPWpGaD
